Research Use Only. This compound is not intended for human consumption or therapeutic use.
Where to Buy Raloxifene: Vendor Comparison & Research Info
Raloxifene Hydrochloride is an investigational selective estrogen receptor modulator (SERM) studied for its tissue-specific effects on estrogen signaling. Research focuses on breast tissue, bone metabolism, lipid pathways, endocrine regulation, and estrogen receptor activity.
What is Raloxifene?
Raloxifene hydrochloride is a second-generation selective estrogen receptor modulator (SERM) investigated for its tissue-specific effects on estrogen receptor signaling. Originally developed for applications involving bone health and estrogen-responsive tissues, raloxifene has become an important research compound for studying estrogen receptor activity in breast tissue, bone, liver, and reproductive biology.
Unlike compounds that uniformly block estrogen signaling throughout the body, raloxifene demonstrates tissue-selective activity. It generally acts as an estrogen receptor antagonist in breast tissue while exhibiting estrogen-like activity in bone. This distinctive pharmacological profile makes it valuable for investigating how estrogen receptors produce different biological responses depending on the target tissue.
Key Research Areas
Estrogen Receptor Signaling: Investigating tissue-specific estrogen receptor activation and antagonism.
Breast Tissue Research: Studying estrogen-dependent cellular proliferation and receptor-mediated signaling.
Bone Biology: Examining estrogen receptor pathways involved in bone remodeling and mineral density.
Lipid Metabolism: Investigating estrogen-related effects on cholesterol and lipid pathways.
Endocrine Research: Studying selective estrogen receptor modulation and hormonal feedback mechanisms.
Cellular Signaling: Exploring differences in estrogen receptor co-regulator recruitment between tissues.
Mechanism of Action
Raloxifene binds to estrogen receptors and produces different downstream responses depending on the tissue involved. In breast tissue, it primarily functions as an estrogen receptor antagonist, allowing researchers to examine how blocking estrogen-mediated signaling affects cellular proliferation.
In bone tissue, raloxifene exhibits estrogen-like activity and has been extensively studied in relation to bone remodeling and mineral homeostasis. These contrasting effects are associated with differences in receptor conformation and the recruitment of tissue-specific transcriptional co-regulators.
Breast Tissue Research
Raloxifene is widely investigated in experimental models involving estrogen-responsive breast tissue. Researchers use the compound to examine estrogen receptor signaling, cellular proliferation, and molecular mechanisms involved in estrogen-dependent tissue development.
Its antagonist activity in mammary tissue has also made raloxifene relevant to research into estrogen-sensitive breast conditions and receptor-mediated cellular responses.
Bone Research
Estrogen signaling plays an important role in maintaining skeletal tissue. Raloxifene has been studied extensively for its ability to influence estrogen-responsive pathways in bone, including mechanisms associated with osteoblast and osteoclast activity, bone remodeling, and mineral preservation.
Lipid and Metabolic Research
Raloxifene is also investigated for its effects on hepatic estrogen receptor signaling and lipid metabolism. Experimental studies have examined changes in cholesterol-related pathways and other metabolic markers associated with selective estrogen receptor modulation.
Research Considerations
Raloxifene is a pharmacologically active SERM with tissue-specific effects and potential adverse effects. Research involving this compound should account for its effects on coagulation, cardiovascular parameters, liver function, and other estrogen-responsive systems.
Its established pharmacological activity does not imply suitability for unsupervised human use, and appropriate laboratory or clinical protocols should be followed when conducting research.
Analytical Quality
Research-grade raloxifene hydrochloride should undergo appropriate analytical testing to verify identity, purity, and batch consistency. Common analytical methods include:
High-Performance Liquid Chromatography (HPLC)
Mass Spectrometry (MS)
Chemical identity verification
Purity assessment
Batch consistency testing
Research Use Only: This compound is intended exclusively for laboratory and scientific research. It is not intended for human consumption, therapeutic use, performance enhancement, diagnostic applications, or veterinary use.
Where to Buy Raloxifene Online
| Rank | Vendor | Trust Score | Vial Size | Price / mg | Status | Action |
|---|---|---|---|---|---|---|
1 | ![]() Dragon Peptides Verified | 9.0/10 Editorial Rating | $116.00 60mg vial | $1.93/mg | In Stock | Visit Site |
Top-Ranked Vendor

At Dragon Peptides, we are committed to supplying high-quality research peptides and compounds to scientists, laboratories, and professionals worldwide. Our company was founded on the principles of reliability, transparency, and customer satisfaction. We work closely with trusted manufacturers and testing facilities to ensure every product we offer meets strict quality standards. Our goal is to provide a dependable source for research products while maintaining a user-friendly and secure online experience. We continually expand and refine our product selection to support evolving research needs.
Chemical Properties & Handling
Standard storage protocols for lyophilized peptides generally apply unless otherwise specified.
- Lyophilized (Powder): Store at -20°C for up to 3 years. Keep away from direct light and moisture.
- Reconstituted (Liquid): Store at 2-8°C (refrigerated) and use within 20-30 days to maintain stability.
Research Reviews
No Research Reviews Yet
Be the first to share your research protocol and vendor experience with Raloxifene.